je.st
news
Celgene Maintains Earnings Promises, But Jolts The Balance Sheet And Returns
2016-02-17 15:53:13| Biotech - Topix.net
However, the balance sheet was levered up, and Return on Capital Invested took a hit in order to maintain aggressive growth aspirations. Recently, bio-pharma heavyweight Celgene Corp. reported another set of solid 4Q and full-year results.
Tags: returns
balance
sheet
earnings
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||